Caretha Creasy

Caretha Creasy has over 20 years of work experience in the biopharmaceutical industry. Caretha has held various leadership roles at UroGen Pharma and GSK.

At UroGen Pharma, Caretha currently serves as the Vice President of Early Development since March 2022. Prior to that, they were the Senior Director of Early Development from February 2021 to March 2022.

At GSK, Caretha held multiple positions from 2001 to 2021. Caretha'smost recent role was as the Oncology Early Development Leader from October 2016 to February 2021. Caretha also served as the Head of Clinical Biomarkers and Translational Research from December 2014 to July 2018, Head of Molecular Medicine from February 2014 to December 2014, Director of Biology and Translational Medicine from September 2008 to February 2014, Director of the Oncology Discovery Technology Group from October 2006 to September 2008, Director of Pathway Genomics from May 2005 to October 2006, Manager of Pathway Genomics from September 2004 to May 2005, and Manager of Comparative Genomics from April 2001 to September 2004.

Caretha Creasy completed their Bachelor of Arts (B.A.) degree in Biochemistry & Molecular Biology at the University of Maryland Baltimore County from 1984 to 1988. Caretha then pursued a Doctor of Philosophy (Ph.D.) in Molecular and Cellular Biology at Ohio University from 1988 to 1993. No information is available regarding their educational experience at Lansdowne.